Pulmonary Arterial Hypertension Clinical Trials in Torrance, California

3 studies are recruiting for pulmonary arterial hypertension in Torrance, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

    The primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP compared with placebo on exercise capacity in adults with PAH.

    Stage
    Phase 3
    Ages
    18 to 75
    Site
    USA005, Torrance, California
    Locations
    26 in total
    Run by
    Insmed Incorporated

    See if you can join NCT07481981 on ClinicalTrials.gov

  2. A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

    Researchers are looking for more ways to treat PAH. In PAH, the blood vessels in the lungs become thick and narrow, which makes it harder for blood to flow. This causes high blood pressure in the lungs and overworks the heart. PAH can make it hard to breathe and be active. Some standard (usual) tre…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center ( Site 1028), Torrance, California
    Locations
    136 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT07218029 on ClinicalTrials.gov

  3. An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

    This is an adaptive, 2-part, randomized, multicenter, double-blind, placebo-controlled, parallel-group study designed to evaluate the efficacy and safety of IKT-001 in adult participants with WHO Group 1 PAH.

    Stage
    Phase 3
    Ages
    18 to 75
    Site
    Lundquist at Harbor UCLA, Torrance, California
    Locations
    43 in total
    Run by
    Inhibikase Therapeutics

    See if you can join NCT07365332 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.